0001171843-20-002465.txt : 20200407 0001171843-20-002465.hdr.sgml : 20200407 20200407174906 ACCESSION NUMBER: 0001171843-20-002465 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200403 FILED AS OF DATE: 20200407 DATE AS OF CHANGE: 20200407 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wei Binxian CENTRAL INDEX KEY: 0001773586 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33672 FILM NUMBER: 20780601 MAIL ADDRESS: STREET 1: P.O. BOX 2231 CITY: LIVINGSTON STATE: NJ ZIP: 07039 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seneca Biopharma, Inc. CENTRAL INDEX KEY: 0001357459 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 522007292 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20271 GOLDENROD LANE STREET 2: STE 2024 CITY: GERMANTOWN STATE: MD ZIP: 20876 BUSINESS PHONE: 301-366-4841 MAIL ADDRESS: STREET 1: 20271 GOLDENROD LANE STREET 2: STE 2024 CITY: GERMANTOWN STATE: MD ZIP: 20876 FORMER COMPANY: FORMER CONFORMED NAME: Neuralstem, Inc. DATE OF NAME CHANGE: 20060324 4 1 ownership.xml X0306 4 2020-04-03 0 0001357459 Seneca Biopharma, Inc. SNCA 0001773586 Wei Binxian 20271 GOLDENROD LANE, 2ND FLOOR GERMANTOWN MD 20876 1 0 0 0 Restricted Stock Units 2020-04-03 4 A 0 6000 0.00 A Common Stock 6000 6000 D Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. N/A /s/ Binxian Wei 2020-04-07